Insulin Detemir in Combination with Oral Antidiabetic Drugs Improves Glycemic Control in Persons with Type 2 Diabetes in Near East Countries: Results from the Lebanese Subgroup.

CONCLUSIONS: Initiating insulin detemir in a clinical health care setting among Lebanese with type 2 diabetes mellitus on OADs improves glycemic control with no increase in hypoglycemia, adverse events or weight compared with baseline. PMID: 28115821 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/28115821?dopt=Abstract

Source: Ethnicity and Disease - January 26, 2017 Category: Global & Universal Tags: Ethn Dis Source Type: research